The gross proceeds from the offering, before deducting the underwriting discounts and commissions and offering expenses payable by Outlook Therapeutics are expected to be approximately $13.0 million.

Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company focused on enhancing the standard of care for bevacizumab for the treatment of retina diseases, today announced that it has ...

Intel Corporation, Qualcomm Incorporated, Advanced Micro Devices Inc. Read 's Market Analysis on Investing.com ...

Nvidia (NASDAQ: NVDA) stock has seen some volatile trading lately. After sinking in response to concerns about the demand ...

Advanced Micro Devices, Inc. continues to show strong growth, especially in AI and data center segments. Learn more about AMD ...

US stock futures slide after Moodys downgraded the countrys credit rating from “Aaa” to “Aa1,” raising alarm over Americas ...

Advanced Micro Devices shares fell Thursday after gaining ground for six consecutive days amid optimism about recently announced AI deals and share buyback plans. Monitor these crucial support and ...

Financial Highlights for the Fiscal Second Quarter Ended March 31, 2025 ...

Advanced Micro Devices stock (NASDAQ:AMD) increased by more than 4% during Tuesday's trading session and has risen by nearly ...

As the Trump administration’s trade war clouds the economic outlook, software stocks have emerged as a favorite place for investors looking for a respite.

Advanced Micro Devices Inc. was already “uncompetitive” in the artificial-intelligence market, according to Bernstein Research. Now the company can’t sell its AI accelerators in China and it ...

AMD stock price has bounced back in the past few days as investors cheered the company’s upbeat financial results.